ID;Term;Depth;IC Nuno;IC zhou;IC sanchez;IC resnik;IC RZ;IC Rnormalized;IC Nuno org;Annotated Genes Set number
GO:0035264;multicellular organism growth;3.0;1.0;0.6981203125901445;9.628524252492122;22.582921643529833;5.382624473008031;7.558300640989654E-4;0.47338797845741154;[BRCA2, HHEX, SLITRK6, HOXA5, RMI1]
GO:0016525;negative regulation of angiogenesis;8.0;0.811012628672052;0.780506314336026;9.32314260294094;151.1079732353669;5.192106149009898;0.005057447875840929;0.6405245499179943;[FASLG, PRL, HHEX, HOXA5, CCR2, HGS, CX3CR1, PLK2, TIE1, CXCL10, TEK, PF4]
GO:0060441;epithelial tube branching involved in lung morphogenesis;7.0;0.9326813400603323;0.8172600352873667;9.533214072687796;53.5045405888233;7.004484905440688;0.0017907488225476112;0.7091290490632969;[HHEX, HOXA5]
GO:0060480;lung goblet cell differentiation;7.0;1.0;0.8509193652572005;9.628524252492122;75.97992412077276;8.67846133901236;0.0025429796828299986;0.7947362817240173;[HOXA5]
GO:0008584;male gonad development;5.0;1.0;0.7902410118609202;9.628524252492122;50.96471695749156;5.2552850506314295;0.001705743211299806;0.5589965337459591;[HMGB2, HOXA11, PDGFRB, LHCGR, BIK, INHBA, NASP, MSH2, KIT]
GO:0060065;uterus development;4.0;1.0;0.75;9.628524252492122;49.86610466882393;7.138016298065211;0.0016689736466849693;0.6150384854347593;[MYOCD, HOXA11]
GO:0006366;transcription by RNA polymerase II;10.0;0.6039883530135606;0.7172351883677006;8.613793447804714;583.8786478812184;3.2909128387363804;0.01954189288791682;0.5835384474769965;[EHF, CCNH, SPIB, MYB, HOXA5, MEF2C, HOXB2, HOXB7, ATF3, HOXB5, EGR1, EGR2, BCL11B, PAX5, FLNA, GTF2H1, ARID4A, C5AR1, HMGA1, MAFF, MYOCD, CREB5, CEBPE, MEIS2, KLF5, POU2AF1, RBMX]
GO:0045446;endothelial cell differentiation;5.0;0.7866048967936545;0.6835434602577475;8.935377071932177;24.20171999872632;6.599019797332524;8.100097882234571E-4;0.6277151911823093;[TMEM100, JAG1, HOXB5]
GO:0045944;positive regulation of transcription by RNA polymerase II;11.0;0.5461734764479651;0.7055156905536448;8.363590748376499;1463.8556817380634;2.718315475161805;0.048993932283191266;0.5714437321440341;[EHF, PID1, SPIB, MYB, AKT1, HOXA5, MEF2C, HOXB9, HOXB4, HOXB2, HOXB7, ATF3, HOXB5, JAG1, JUP, FZD5, PAX5, MMP12, ENG, EPCAM, NR1H2, ATAD2, GTF2H1, PF4, PLXND1, FOXO1, CXCL10, MAFF, CIITA, HHEX, CEBPE, E2F5, E2F7, KLF5, POU2AF1, CCNH, TNFSF11, DPF3, SLC11A1, EBF1, FLT3LG, RUNX2, BEX1, EGR1, EGR2, EGR3, BCL11B, CD28, PRL, RGMA, TLR4, TLR2, LILRB1, IL17A, ARID4A, ADRB2, NLRP3, TGFB1, HMGA1, INHBA, NR4A2, NR4A1, TCF4, HMGB2, SLC40A1, ARHGEF10L, MYOCD, CKAP2, DLL1, MEIS2, RBMX]
GO:0045647;negative regulation of erythrocyte differentiation;8.0;0.9326813400603323;0.8413406700301662;9.582004236857228;359.6763559852469;7.697632086000634;0.012038043947121413;0.7686572628545723;[HOXA5]
GO:0048539;bone marrow development;5.0;1.0;0.7902410118609202;9.628524252492122;32.5184652959493;7.697632086000634;0.001088363768736683;0.6838982747154925;[HOXB4]
GO:0060644;mammary gland epithelial cell differentiation;5.0;0.8259837884571596;0.7032329060895001;9.117698628726131;24.20171999872632;6.943860283624253;8.100097882234571E-4;0.6453503496879909;[AKT1, HOXA5]
GO:0060326;cell chemotaxis;5.0;0.6393367784920305;0.6099094011069355;8.152617732682543;30.286927728949156;4.458953633836253;0.0010136762146226118;0.5182721080578558;[CSF3R, CXCL13, CXCL16, LGALS3, EDNRB, CCRL2, C3AR1, TNFSF11, IL6R, PDGFRB, CXADR, HOXB9, AGTR1, S100A8, C5AR1, FPR1, FPR3, FPR2, TNFRSF11A, CORO1A, NUP85, CCR10, CCR1, EGR3, AZU1, DEFA1, PPBP, NR4A1, CXCL10, CXCL11, CXCL12, NRP1, CXCL6, CXCL9, HMGB2, CXCL1, CXCL3, CXCL2, CXCL5, CCR9, FFAR2, CCR6, CCR5, CCR2, ANXA1, RHOG, GAB1, KIT, XCL1, HBEGF, CX3CR1, CCL13, CXCR5, CXCR4, CXCR6, CCL8, CXCR1, CCL7, CCL5, CXCR2, CCL4, CCL2, CCL1, CCL19, CCL18, CCL23, CCL20, PF4]
GO:0000122;negative regulation of transcription by RNA polymerase II;11.0;0.6073376606709605;0.7360977826651425;8.793202583151634;1836.9481969605868;3.0544438328250214;0.0614810030062249;0.5886333519864981;[EHMT2, SLA2, MYB, MEF2C, HOXB4, ATF3, ELANE, PKIG, EZH2, PAWR, PAX5, AES, MMP12, NR1H2, DACH1, TLE4, FOXO1, NACC2, WFS1, BCL6, CIITA, FASLG, HHEX, RFC1, RBBP8, E2F7, KLF8, KLF5, UXT, ZNF608, EDNRB, PCBP3, EGR1, BCL11A, XPO1, CD36, CCNE1, TGFB1, CBX4, CAV1, NR4A2, MXD1, MYOCD, IFNG, FBP1, MEIS2]
GO:2000738;positive regulation of stem cell differentiation;6.0;0.7763722522362496;0.7113064387082693;9.193206181234276;114.95643040877245;6.832634648514029;0.003847488271711053;0.6725415662651573;[TACSTD2, HOXB4, LTBP3]
GO:0045893;positive regulation of transcription, DNA-templated;10.0;0.5159906454948852;0.673236334608363;8.141425192250265;1208.1179641469014;2.4745772039531437;0.04043462102441837;0.5417910051506925;[PID1, SPIB, AKT1, MEF2C, PADI2, ATF3, JAG1, JUP, MMP12, ATAD2, LGR4, BLM, FOXO1, CXCL10, CIITA, HHEX, E2F5, E2F7, POU2AF1, CCNH, TNFSF11, EGR1, EGR2, EGR3, CD28, BRCA2, RGMA, IL17A, CCNE1, HMGA1, INHBA, TCF4, HMGB2, ARHGEF10L, NUP62, MYOCD, PSRC1, CREB5, EGF, CD4, RAN, EHF, MYB, HOXA5, HOXB9, HOXB4, HOXB2, HOXB7, HOXB5, NUP85, NFE2, FZD5, PAX5, ENG, EPCAM, NR1H2, GTF2H1, PF4, PLXND1, CDH1, MAP2K2, F2R, MAFF, RFC1, SMARCD3, CEBPE, KLF5, CHEK1, DPF3, SLC11A1, EBF1, FLT3LG, RUNX2, BEX1, BCL11B, IFNA2, PRL, RHOG, TLR4, TLR2, LILRB1, CAMK4, ARID4A, HOXA11, ADRB2, NLRP3, TGFB1, NR4A2, NR4A1, SLC40A1, CKAP2, DNM2, DLL1, MEIS2, RBMX]
GO:0033599;regulation of mammary gland epithelial cell proliferation;6.0;0.8653626801206646;0.7558016526504768;9.34084218004034;45.58987593597882;6.8867018697843045;0.0015258521193526465;0.6753065664753021;[BRCA2, IQGAP3, PHB2, HOXA5]
GO:0060070;canonical Wnt signaling pathway;8.0;0.6729672293956388;0.7114836146978194;8.391761625343195;31.415129658942366;5.233778845410465;0.0010514361179036673;0.6426556935498979;[LRRK2, CDH3, FZD5, EGF, TMEM64, NR4A2, HOXB9, SDC1, LGR4]
GO:0010870;positive regulation of receptor biosynthetic process;7.0;0.8436909121759173;0.7727648213451592;9.466005322994347;258.61903890750995;7.379178354882098;0.008655746490210232;0.728290889492758;[HOXA5]
GO:0035115;embryonic forelimb morphogenesis;6.0;1.0;0.8231203125901445;9.628524252492122;58.806290969860136;6.343086423195323;0.001968193636535348;0.647506047256038;[RUNX2, HOXA11]
GO:0045638;negative regulation of myeloid cell differentiation;7.0;0.7307253602413294;0.7162820453778652;9.186691500213083;279.0827475916144;5.4730085344763;0.00934064840372507;0.6308092762312435;[HOXA9, GPR171, HOXA5, CEACAM1, TLR4, LTF, DLL1, LYN, LILRB1, INHBA, LILRB3, MEIS2, PF4]
GO:0060574;intestinal epithelial cell maturation;6.0;1.0;0.8231203125901445;9.628524252492122;41.35061092186203;8.390779266560578;0.0013839677344209735;0.7522251544931926;[CDKN1A, HOXA5]
GO:0045639;positive regulation of myeloid cell differentiation;7.0;0.7307253602413294;0.7162820453778652;9.186691500213083;278.20784311065285;5.311165509025885;0.0093113661381102;0.622532616383239;[HMGB2, TNFSF11, HOXA5, IFNG, CCR1, JAG1, INHBA, TMEM64, CD4, ACIN1, PF4, IL17A]
GO:0006351;transcription, DNA-templated;9.0;0.5708408884191841;0.6816610693898811;8.449869256150476;581.393741231429;1.9872050686257638;0.019458725298619164;0.49786638480429696;[SPIB, MEF2C, PADI4, ATF3, EZH2, CHAF1B, FLNA, ZNF467, ATAD2, PKN1, RUVBL1, FOXO1, CIITA, FASLG, HHEX, E2F5, E2F7, POU2AF1, CCNH, UXT, BTK, EGR1, EGR2, EGR3, HMGA1, MXD1, HMGB2, AFF3, NUP62, MYOCD, CREB5, EHF, PHB2, HOXA9, MYB, HOXA5, HOXA4, HOXB9, HOXB4, HOXB2, HOXB7, HOXB6, HOXB5, NFE2, ZNF367, BRD2, PAWR, PAX5, AES, GTF2H1, TLE4, NACC2, BCL6, CNOT3, MAFF, RFC1, SMARCD3, CEBPE, KLF8, KLF5, ZNF608, DPF3, EBF1, BCL11B, BCL11A, ARID4A, HOXA11, C5AR1, NLRP3, CBX4, NR4A2, KDM5D, LTF, MEIS2, RBMX]
GO:0060272;embryonic skeletal joint morphogenesis;6.0;0.9326813400603323;0.7894609826203107;9.510741216835738;46.18089108149027;7.292166977892469;0.0015456328643938164;0.6960420709600095;[HOXA11]
GO:0060218;hematopoietic stem cell differentiation;5.0;1.0;0.7902410118609202;9.628524252492122;45.53364894725875;7.379178354882098;0.0015239702526411902;0.6676125360964777;[ACE, HOXB4]
GO:0048704;embryonic skeletal system morphogenesis;5.0;0.8653626801206646;0.7229223519212526;9.377209824211215;45.48774390093071;5.346256828837156;0.0015224338520524504;0.5636488347140203;[HOXA11, HOXA5, HOXA4, PAX5, RUNX2, HOXB4, HOXB2, HOXB7, HOXB6, HOXB5]
GO:0060435;bronchiole development;5.0;1.0;0.7902410118609202;9.628524252492122;30.901059213865338;9.083926447120524;0.0010342306427403032;0.7547934328124444;[HOXA5]
GO:0006357;regulation of transcription by RNA polymerase II;10.0;0.43649654099988644;0.6334892823608635;7.109131426632953;248.56913769389934;1.8913682364374496;0.008319385340914571;0.5119656714299493;[PID1, EHMT2, SLA2, SPIB, AKT1, MEF2C, ATF3, JAG1, JUP, PKIG, EZH2, MMP12, PTAFR, ZNF467, USP9Y, ATAD2, PKN1, RUVBL1, MAZ, FOXO1, CXCL10, CIITA, FASLG, HHEX, E2F5, E2F7, POU2AF1, CCNH, UXT, TNFSF11, TGFA, PCBP3, EGR1, EGR2, EGR3, CD28, CD36, RGMA, KIT, IL17A, NR3C2, CCNE1, CAV1, HMGA1, INHBA, TCF4, MXD1, HMGB2, ARHGEF10L, MYOCD, FBP1, CREB5, EHF, HOXA9, MYB, HOXA5, HOXA4, HOXB9, HOXB4, HOXB2, HOXB7, HOXB6, HOXB5, ELANE, NFE2, FZD5, CDKN1A, ZNF367, HAVCR2, BRD2, PAWR, PAX5, AES, ENG, EPCAM, NR1H2, GTF2H1, PF4, PLXND1, DACH1, TLE4, NACC2, WFS1, BCL6, MAFF, RFC1, SMARCD3, CEBPE, RBBP8, KLF8, KLF5, PPIL4, ZNF608, EDNRB, CHEK1, DPF3, SLC11A1, EBF1, FLT3LG, RUNX2, PFN1, BEX1, BCL11B, BCL11A, PRL, XPO1, TLR4, TLR2, LILRB1, ARID4A, HOXA11, ADRB2, NLRP3, TGFB1, CBX4, NR4A2, NR4A1, KDM5D, SLC40A1, TMEM100, CKAP2, TGFBR3, IFNG, DLL1, MEIS2, RBMX]
GO:0060535;trachea cartilage morphogenesis;5.0;1.0;0.7902410118609202;9.628524252492122;28.830748707783577;8.390779266560578;9.649392132602356E-4;0.7193458537639684;[HOXA5]
GO:0090190;positive regulation of branching involved in ureteric bud morphogenesis;8.0;1.0;0.875;9.628524252492122;298.04283299406984;6.832634648514029;0.009975225399176214;0.7244212536750128;[TGFB1, HOXB7, LGR4]
GO:0001658;branching involved in ureteric bud morphogenesis;7.0;1.0;0.8509193652572005;9.628524252492122;53.5045405888233;6.015873511986907;0.0017907488225476112;0.6585714164269392;[HOXA11]
GO:0043065;positive regulation of apoptotic process;7.0;0.5587538620495764;0.6302962962819887;7.806911820114386;80.91235068524658;3.3969510907807043;0.0027080635610472266;0.5246396020141064;[MYB, AKT1, HOXA5, MEF2C, ATF3, SFN, BARD1, LYN, NOX4, ANXA1, DUSP1, PAWR, DUSP6, AES, PTGS2, FGD4, GSN, BIK, G0S2, CTGF, PYCARD, F2R, MELK, MAL, S100A8, CD274, FOXO1, NACC2, TNFRSF10B, BCL6, FASLG, NLRC4, CCL5, CCL2, P2RX1, PPP2R1A, SIK1, TNFSF12, ITM2C, CXCR2, SORT1, LILRB1, PPP1CA, NLRP12, PDGFRB, NLRP3, TGFB1, CAV1, INHBA, UBE2M, MMP9, DNM2, IFNG, CNR1, LTBR]
GO:0030099;myeloid cell differentiation;4.0;0.6913464685778243;0.5956732342889122;8.146919711567906;21.066225782797595;4.720827822332161;7.050676185779127E-4;0.49142335437501145;[TFRC, CLEC5A, TNFSF11, MEF2C, ACTN1, OSCAR, PRTN3, HOXB7, TNFRSF11A, RASGRP4, LYN, TGFB1, NBEAL2, INHBA, TREM2, HHEX, MMP9, TGFBR3, KIT, CEBPE, CCL19, CAMK4, ACIN1, LTBR]
GO:0001759;organ induction;7.0;0.8436909121759173;0.7727648213451592;9.377209824211215;112.34202169575063;7.212124270218933;0.0037599863649012966;0.7197477358342742;[HOXA11]
GO:0010720;positive regulation of cell development;6.0;0.5342313985608436;0.5902360118705663;7.526609854960228;116.56586832120823;3.570497700955542;0.0039013547102401953;0.5057157310621343;[CYFIP1, CPNE5, MYB, TNFSF11, MEF2C, SPINT1, EPHA3, LYN, EZH2, ROBO2, NRP1, CCR2, KIT, TLR2, CXCR4, PAK1, FLNA, SCARB2, PLXND1, HOXA11, CDH5, OLFM4, SYT2, CXCL12, LIN28A, BCL6, TCF4, DOCK5, DNM2, CX3CR1, NLGN1, SMARCD3, CNR1]
GO:0032332;positive regulation of chondrocyte differentiation;7.0;0.8933024483968273;0.7975705894556142;9.567899630675686;229.711107350086;6.832634648514029;0.007688224036432589;0.7003406189322132;[POR, RUNX2, HOXA11]
